Xinmin Zhao

Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies

Li Jin, Xinmin Zhao, Lei Chen et al. · BMC Cancer · 2010 · 274 citations · Full text

Pharmacy, Oncology, Pharmacology +15

Variability of <i>EGFR</i> exon 20 insertions in 24 468 Chinese lung cancer patients and their divergent responses to EGFR inhibitors

Yanru Qin, Hong Jian, Xiaoling Tong et al. · Molecular Oncology · 2020 · 76 citations · Full text

Medicine, Molecular Genetics, Oncology +16

USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51‐AKT1 signaling

Xinmin Zhao, Xianghua Wu, Huijie Wang et al. · Molecular Carcinogenesis · 2020 · 42 citations

Medicine, Cancer Biology, Oncology +17

Lactate Dehydrogenase 5 Expression in Non-Hodgkin Lymphoma Is Associated with the Induced Hypoxia Regulated Protein and Poor Prognosis

Renquan Lu, Minglei Jiang, Zhujun Chen et al. · PLoS ONE · 2013 · 39 citations · Full text

Life Sciences, Biochemistry, Oncology +16

Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor

Ying Lin, Bo Yu, Haifeng Sun et al. · Journal of Cancer Research and Clinical Oncology · 2023 · 39 citations · Full text

Medicine, Immunology, Oncology +16